Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.38 HKD
Change Today +0.22 / 18.97%
Volume 5.6M
As of 4:01 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin teda biomedical-h (8189) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/24/15 - $1.50
52 Week Low
11/10/14 - $0.56
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TIANJIN TEDA BIOMEDICAL-H (8189)

Related News

No related news articles were found.

tianjin teda biomedical-h (8189) Related Businessweek News

No Related Businessweek News Found

tianjin teda biomedical-h (8189) Details

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, is engaged in the research, development, manufacture, and sale of biological compound fertilizer products and health care products in the People’s Republic of China. It operates in two segments, Compound Fertilizers Products and Health Care Products. The company markets its biological compound fertilizer products under the Fulilong brand, which are used for the balanced growth of grains, fruits, and vegetables. It also offers a series of health care products under the Alpha brand comprising diabetic health care products and related products with the function of regulating the blood sugar level; and various sugar-free products, including beverages, low glucose cookies, cereals, calcium-rich milk powder, and mooncakes. The company was founded in 2000 and is headquartered in Tianjin, the People's Republic of China.

500 Employees
Last Reported Date: 03/27/15
Founded in 2000

tianjin teda biomedical-h (8189) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: CNY485.6K
Vice Chairman
Total Annual Compensation: CNY447.2K
Qualified Accountant and Company Secretary
Total Annual Compensation: CNY150.0K
Compensation as of Fiscal Year 2013.

tianjin teda biomedical-h (8189) Key Developments

Tianjin TEDA Biomedical Engineering Company Limited Appoints Guan Tong as the Chairman of the Audit Committee

Tianjin TEDA Biomedical Engineering Company Limited announced that Mr. Guan Tong has been appointed as the chairman of the Audit committee due to his professional qualifications in accounting and auditing experience.

Tianjin TEDA Biomedical Engineering Company Limited Reports Audited Consolidated Earnings Results for the Year Ended Dec. 31, 2014

Tianjin TEDA Biomedical Engineering Company Limited reported audited consolidated earnings results for the year ended Dec. 31, 2014. For the year, the company reported turnover of RMB 552,041,373 compared to RMB 583,111,851 a year ago. Profit before income tax expenses was RMB 26,785,249 compared to RMB 24,747,406 a year ago. Profit and total comprehensive income for the year attributable to owners of the company was RMB 17,787,428 or 1.25 cents per basic and diluted share compared to RMB 21,373,605 or 1.51 cents per basic and diluted share a year ago. Net cash generated from operating activities was RMB 19,427,774 against net cash used in operating activities of RMB 10,652,044 a year ago. Purchase of property, plant and equipment was RMB 22,594,575 against RMB 8,024,108 a year ago.

Tianjin TEDA Biomedical Engineering Company Limited to Report Fiscal Year 2014 Final Results on Mar 25, 2015

Tianjin TEDA Biomedical Engineering Company Limited announced that they will report fiscal year 2014 final results on Mar 25, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8189:HK $1.38 HKD +0.22

8189 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8189.
View Industry Companies

Industry Analysis


Industry Average

Valuation 8189 Industry Range
Price/Earnings 88.2x
Price/Sales 2.8x
Price/Book 7.9x
Price/Cash Flow 88.2x
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN TEDA BIOMEDICAL-H, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at